ArticleCureus2026
Vallecular Large B-Cell Lymphoma: An Uncommon Presentation of Follicular-Origin Disease.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The vallecula is a mucosal recess of the hypopharynx situated between the base of the tongue and the lingual surface of the epiglottis and bordered laterally by the glossoepiglottic folds. Lesions in this region are uncommon and encompass a broad differential diagnosis, including vallecular cysts, lingual tonsil hypertrophy, minor salivary gland tumors, squamous cell carcinoma, and, rarely, lymphoproliferative disease. Primary extranodal non-Hodgkin lymphoma of the vallecula is exceptionally rare, and follicular large B-cell lymphoma (FLBCL) has not previously been reported at this site. We present the case of a 62-year-old man who presented with progressive dysphagia and persistent globus sensation for 2-3 months. Flexible laryngoscopy demonstrated a well-circumscribed, smooth, cystic-appearing, pedunculated vallecular mass without mucosal ulceration or airway compromise. The patient underwent direct microlaryngoscopy with transoral excisional biopsy. Histopathologic evaluation revealed a high-grade lymphoid neoplasm. Immunophenotyping demonstrated positivity for cluster of differentiation 20 (CD20), cluster of differentiation 10 (CD10), and B-cell lymphoma 6 (BCL6), with co-expression of B-cell lymphoma 2 (BCL2), an elevated Ki-67 proliferation index, and light-chain restriction. Fluorescence in situ hybridization excluded common rearrangements, supporting a diagnosis of CD10-positive LBCL of follicular germinal center origin, classified as FLBCL according to the World Health Organization 5th edition classification of tumors. The patient was treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP), followed by involved-site radiotherapy (30 Gy), and achieved a complete metabolic response on surveillance positron emission tomography at six months. The literature on lymphoma involving the vallecula and tongue base is limited to small series and isolated case reports. Diffuse LBCL (DLBCL) predominates, whereas other histologic subtypes have been reported only sporadically. Presentations are typically characterized by dysphagia and globus sensation, and definitive diagnosis requires adequate tissue sampling. To our knowledge, this case represents the first reported occurrence of FLBCL arising in the vallecula. Lymphoma should be considered in the differential diagnosis of atypical or persistent vallecular masses, and adequate submucosal tissue sampling is essential for establishing the diagnosis, particularly in lesions with benign-appearing features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.